Clinical Trial Update: Study of TFX06 in Women With Advanced Breast Cancer. [Phase 1, Phase 2]

View source ↗

Summary

A trial update for TFX06 in women with advanced breast cancer spanning Phase 1 and Phase 2; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TFX06

Snippet

Sponsor: Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | Conditions: ER+, HER2- Advanced Breast Cancer, Metastatic Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN